Samuel Agresta - Aug 16, 2023 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Medical Officer
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
Aug 16, 2023
Transactions value $
-$1,410,175
Form type
4
Date filed
8/18/2023, 04:03 PM
Previous filing
Jan 30, 2023
Next filing
Sep 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Options Exercise $1.16M +311K $3.72 311K Aug 16, 2023 Direct
transaction FHTX Common Stock Sale -$2.57M -311K -100% $8.25 0 Aug 16, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Options Exercise $0 -311K -100% $0.00* 0 Aug 16, 2023 Common Stock 311K $3.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until fully vested.